squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery#245503ClinicalTrials.gov
• European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]#878851ClinicalTrials.gov
• Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer#878762ClinicalTrials.gov
• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma#827716ClinicalTrials.gov
• Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial#873753ClinicalTrials.gov
• Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma#874479ClinicalTrials.gov
• Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma#307460ClinicalTrials.gov
• Investigation of Desmoplastic Squamous Cell Carcinoma#849186ClinicalTrials.gov
• Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)#18616ClinicalTrials.gov
• Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck#900957ClinicalTrials.gov
• Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma#481746ClinicalTrials.gov
• Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)#893457ClinicalTrials.gov
• Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma#803913ClinicalTrials.gov
• Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin#883387ClinicalTrials.gov
• Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers#843657ClinicalTrials.gov
• Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck#875418ClinicalTrials.gov
• Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck#873306ClinicalTrials.gov
• Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck#387165ClinicalTrials.gov
• AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer#813112ClinicalTrials.gov
• S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer#849755ClinicalTrials.gov
• Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel#230434ClinicalTrials.gov
• Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer#859589ClinicalTrials.gov
• A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)#839475ClinicalTrials.gov
• Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer#887818ClinicalTrials.gov
• Amivantamab in Patients With Metastatic/Recurrent Penile Squamous Cell Carcinoma#836451ClinicalTrials.gov
• Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer#890634ClinicalTrials.gov
• Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma#272363ClinicalTrials.gov
• ctDNA in Cutaneous Squamous Cell Carcinoma#451480ClinicalTrials.gov
• New Strategies Against Cutaneous Squamous Cell Carcinoma#827815ClinicalTrials.gov
• Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients#846505ClinicalTrials.gov
• S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer#857416ClinicalTrials.gov
• Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer#876718ClinicalTrials.gov
• Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma#349907ClinicalTrials.gov
• Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma#876987ClinicalTrials.gov
• Towards Cure Via Only Ultra-short ICB in CSCC#152388ClinicalTrials.gov
• Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma#444887ClinicalTrials.gov
• Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer#234434ClinicalTrials.gov
• Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma#463712ClinicalTrials.gov
• Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment#252997ClinicalTrials.gov
• Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck#303591ClinicalTrials.gov
• EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer#838260ClinicalTrials.gov
• S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer#857723ClinicalTrials.gov
• Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma#28342ClinicalTrials.gov
• Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin#208448ClinicalTrials.gov
• Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer#807698ClinicalTrials.gov
• Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva#872580ClinicalTrials.gov
• Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition#883546ClinicalTrials.gov
• Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer#865360ClinicalTrials.gov
• Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial#802804ClinicalTrials.gov
• Serum Lipid Profile and Lip Squamous Cell Carcinoma#813556ClinicalTrials.gov